OptimizeRx Q3 Adj. EPS $0.20 Beats $0.17 Estimate, Sales $21.615M Beat $21.188M Estimate
Benzinga Newsdesk 4 hours ago
NewsEarningsEarnings Beats
OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.17 by 17.65 percent. This is unchanged from the same period last year. The company reported
OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.17 by 17.65 percent. This is unchanged from the same period last year. The company reported quarterly sales of $21.615 million which beat the analyst consensus estimate of $21.188 million by 2.01 percent. This is a 17.08 percent decrease over sales of $26.067 million the same period last year.